Clinical Trial Update: Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with ivosidenib after allogeneic stem cell transplantation in patients with acute myeloid leukemia or high-risk mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Tibsovo (ivosidenib)

Snippet

Sponsor: Technische Universität Dresden | Conditions: AML, MDS | Phase 2 | Status: RECRUITING